← Leaderboards
Eric Kai Huang
Glympse Bio, Inc.
$1,995,003
Attributed
$1,995,003
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2017–19$2M$1.5M$1M$500K$0
'17
'18
'19
Funding mix
By agency
NIH$1,995,003 · 2
By mechanism
R44$1,995,003 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroLiver TransplantationHealth Care CostsInjectableLiverDetectionDoseFormulationHepaticInflammationDiagnosticIn VivoBaseBenchmarkingCessation Of LifeDesignCharacteristicsDrug KineticsClinical TrialsHealthcare SystemsAnimal ModelCanis FamiliarisDiagnosisMass Spectrometer
Grant awards (4)
Noninvasive urinary monitoring of NASH by activity-based nanosensors$923,177
R44 · FY2019 · DK · contact PI
Early detection of HCC using noninvasive activity-based nanosensors$291,191
R44 · FY2019 · CA · contact PI
Noninvasive urinary monitoring of NASH by activity-based nanosensors$555,976
R44 · FY2018 · DK · contact PI
Noninvasive urinary monitoring of NASH by activity-based nanosensors$224,659
R44 · FY2017 · DK · contact PI